Authors:
Oleszczuk, M
Rodziewicz-Motowidlo, S
Falkiewicz, B
Citation: M. Oleszczuk et al., Restricted rotation in chiral peptide nucleic acid (PNA) monomers - Influence of substituents studied by means of H-1 NMR, NUCLEOS NUC, 20(4-7), 2001, pp. 1399-1402
Authors:
Bielawski, K
Zaczek, A
Lisowska, U
Dybikowska, A
Kowalska, A
Falkiewicz, B
Citation: K. Bielawski et al., The suitability of DNA extracted from formalin-fixed, paraffin-embedded tissues for double differential polymerase chain reaction analysis, INT J MOL M, 8(5), 2001, pp. 573-578
Authors:
Falkiewicz, B
Kolodziejczyk, AS
Liberek, B
Wisniewski, K
Citation: B. Falkiewicz et al., Synthesis of achiral and chiral peptide nucleic acid (PNA) monomers using Mitsunobu reaction, TETRAHEDRON, 57(37), 2001, pp. 7909-7917
Authors:
Falkiewicz, B
Schlotter, CM
Bosse, U
Bielawski, K
Vogt, U
Citation: B. Falkiewicz et al., c-myc Oncogene gene dosage, serum CEA and CA-15.3 antigen levels, and cellular DNA values in relation to ex vivo chemosensitivity of primary human breast cancer, ACT BIOCH P, 47(1), 2000, pp. 149-156
Authors:
Vogt, U
Falkiewicz, B
Bielawski, K
Bosse, U
Schlotter, CM
Citation: U. Vogt et al., Relationship of c-myc and erbB oncogene family gene aberrations and other selected factors to ex vivo chemosensitivity of ovarian cancer in the modified ATP-chemosensitivity assay, ACT BIOCH P, 47(1), 2000, pp. 157-164
Authors:
Falkiewicz, B
Kowalska, K
Kolodziejczyk, AS
Wisniewski, K
Lankiewicz, L
Citation: B. Falkiewicz et al., Synthesis of new chiral peptide nucleic acid (PNA) monomers by a simplified reductive amination method, NUCLEOS NUC, 18(3), 1999, pp. 353-361
Authors:
Vogt, U
Striehn, E
Bosse, U
Klinke, F
Falkiewicz, B
Citation: U. Vogt et al., Lack of squamous cell lung carcinoma in vitro chemosensitivity to various drug regimens in the adenosine triphosphate cell viability chemosensitivityassay, ACT BIOCH P, 46(2), 1999, pp. 299-302
Authors:
Vogt, U
Bielawski, K
Schlotter, CM
Bosse, U
Falkiewicz, B
Podhajska, AJ
Citation: U. Vogt et al., Amplification of erbB-4 oncogene occurs less frequently than that of erbB-2 in primary human breast cancer, GENE, 223(1-2), 1998, pp. 375-380